KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Other Non-Current Liabilities (2016 - 2024)

Historic Other Non-Current Liabilities for Astrazeneca (AZN) over the last 10 years, with Q4 2024 value amounting to $1.8 billion.

  • Astrazeneca's Other Non-Current Liabilities fell 3345.86% to $1.8 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $1.8 billion, marking a year-over-year decrease of 3345.86%. This contributed to the annual value of $1.8 billion for FY2024, which is 3345.86% down from last year.
  • Astrazeneca's Other Non-Current Liabilities amounted to $1.8 billion in Q4 2024, which was down 3345.86% from $2.7 billion recorded in Q4 2023.
  • In the past 5 years, Astrazeneca's Other Non-Current Liabilities registered a high of $6.1 billion during Q4 2020, and its lowest value of $1.8 billion during Q4 2024.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $4.3 billion (2022), whereas its average is $3.9 billion.
  • As far as peak fluctuations go, Astrazeneca's Other Non-Current Liabilities plummeted by 329.04% in 2020, and later crashed by 3770.49% in 2023.
  • Quarter analysis of 5 years shows Astrazeneca's Other Non-Current Liabilities stood at $6.1 billion in 2020, then fell by 18.92% to $4.9 billion in 2021, then fell by 13.44% to $4.3 billion in 2022, then tumbled by 37.7% to $2.7 billion in 2023, then tumbled by 33.46% to $1.8 billion in 2024.
  • Its Other Non-Current Liabilities was $1.8 billion in Q4 2024, compared to $2.7 billion in Q4 2023 and $4.3 billion in Q4 2022.